18 44

Cited 0 times in

Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening

Authors
 Kayoung Shin  ;  Hyemi Shin  ;  Hee Jin Cho  ;  Hyunju Kang  ;  Jin-Ku Lee  ;  Yun Jee Seo  ;  Yong Jae Shin  ;  Donggeon Kim  ;  Harim Koo  ;  Doo-Sik Kong  ;  Ho Jun Seol  ;  Jung-Il Lee  ;  Hye Won Lee  ;  Do-Hyun Nam 
Citation
 CANCERS, Vol.12(3) : 549, 2020-03 
Journal Title
CANCERS
Issue Date
2020-03
Keywords
use infiltrating glioma ; personalized medicine ; glioma stem cells ; short-term cultivation screening platform ; growth factor ; genomic profiling
Abstract
Diffusely infiltrating gliomas (DIGs) are difficult to completely resect and are associated with a high rate of tumor relapse and progression from low- to high-grade glioma. In particular, optimized short-term culture-enriching patient-derived glioma stem cells (GSCs) are essential for customizing the therapeutic strategy based on clinically feasible in vitro drug screening for a wide range of DIGs, owing to the high inter-tumoral heterogeneity. Herein, we constructed a novel high-throughput culture condition screening platform called 'GFSCAN', which evaluated the cellular growth rates of GSCs for each DIG sample in 132 serum-free combinations, using 13 previously reported growth factors closely associated with glioma aggressiveness. In total, 72 patient-derived GSCs with available genomic profiles were tested in GFSCAN to explore the association between cellular growth rates in specific growth factor combinations and genomic/molecular backgrounds, including isocitrate dehydrogenase 1 (IDH1) mutation, chromosome arm 1p and 19q co-deletion, ATRX chromatin remodeler alteration, and transcriptional subtype. GSCs were clustered according to the dependency on epidermal growth factor and basic fibroblast growth factor (E&F), and isocitrate dehydrogenase 1 (IDH1) wild-type GSCs showed higher E&F dependencies than IDH1 mutant GSCs. More importantly, we elucidated optimal combinations for IDH1 mutant glioblastoma and lower grade glioma GSCs with low dependencies on E&F, which could be an aid in clinical decision-making for these DIGs. Thus, we demonstrated the utility of GFSCAN in personalizing in vitro cultivation to nominate personalized therapeutic options, in a clinically relevant time frame, for individual DIG patients, where standard clinical options have been exhausted.
Files in This Item:
T9992020433.pdf Download
DOI
10.3390/cancers12030549
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Hospital Medicine (입원의학과) > 1. Journal Papers
Yonsei Authors
Lee, Hye Won(이혜원)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190208
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links